Beneath the partnership, RPG Life Sciences will completely market and distribute Naprosyn ES — a mix of Naproxen and Esomeprazole — throughout the nation, and Archerchem because the unique provider, the corporate stated in a press release.
Naprosyn ES is designed to ship an efficient anti-inflammatory answer together with gastroprotection. The mixture has been co-developed by Archerchem Healthcare together with its improvement companion, it added.
“Naprosyn ES is an instance of our sturdy R&D-driven method to differentiated merchandise, and the long-standing belief that medical doctors and sufferers place within the Naprosyn model,” RPG Life Sciences Managing Director, Ashok Nair, stated.
Archerchem Healthcare Chairman & MD Anil Dhedia stated, “This partnership exemplifies Archerchem’s core power in creating complicated differential formulations.”
Via the partnership with RPG Life Sciences, which has a powerful presence in a number of power and acute therapies, together with within the ache administration section, he stated, “We’re proud to ship incremental innovation that enhances remedy adherence and brings significant profit to sufferers throughout India.”
